Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

समान संसाधन

• Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
  द्वारा: Moran, AM, और अन्य
  प्रकाशित: (2020)
• Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
  द्वारा: Shrimanker, R, और अन्य
  प्रकाशित: (2017)
• Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
  द्वारा: Charlene Desaintjean, और अन्य
  प्रकाशित: (2024-03-01)
• Glucocorticoids and mepolizumab in eosinophilic asthma.
  द्वारा: Bel, E, और अन्य
  प्रकाशित: (2014)
• Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
  द्वारा: Andrea Portacci, और अन्य
  प्रकाशित: (2023-10-01)